サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386124

エボラ出血熱治療薬・ワクチン市場レポート：2030年までの動向、予測、競合分析

Ebola Drug and Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

エボラ出血熱治療薬・ワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

エボラ出血熱治療薬・ワクチンの動向と予測

世界のエボラ出血熱治療薬・ワクチン市場は、2024年から2030年までのCAGRが28.6%で、2030年までに推定1億6,870万米ドルに達すると予測されます。この市場の主な促進要因は、感染症の流行が拡大していることと、エボラ出血熱の研究およびエボラ出血熱治療薬・ワクチンの開発に対する政府の積極的な取り組みです。世界のエボラ出血熱治療薬・ワクチン市場の将来は、病院・診療所市場と外来手術センター市場に機会があり、有望視されています。

エボラ出血熱治療薬・ワクチン市場の洞察

Lucintelは、ザイールが予測期間中に最も高い成長を遂げると予測しています。

北米は、人獣共通感染症の流行が拡大していること、先進医療技術の導入が進んでいること、医療インフラが整備されていることから、引き続き最大の地域となるでしょう。

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のエボラ出血熱治療薬・ワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のエボラ出血熱治療薬・ワクチン市場動向（2018～2023年）と予測（2024～2030年）
  • 新規薬剤タイプ別：世界のエボラ出血熱治療薬・ワクチン市場
    • ズマップ
    • ファビピラビル
    • GS-5734
    • Tkm-エボラ出血熱
    • アヴィ-7537
  • ワクチンタイプ別：世界のエボラ出血熱治療薬・ワクチン市場
    • Cad3-ゼボフ
    • ルブ・ゼボフ
    • その他
  • 菌株タイプ別：世界のエボラ出血熱治療薬・ワクチン市場
    • ザイール
    • スーダン
    • タイフォレスト
    • レストン
    • ブンディブギョウイルス
  • 最終用途別：世界のエボラ出血熱治療薬・ワクチン市場
    • 病院とクリニック
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のエボラ出血熱治療薬・ワクチン市場
  • 北米のエボラ出血熱治療薬・ワクチン市場
  • 欧州のエボラ出血熱治療薬・ワクチン市場
  • アジア太平洋エボラ出血熱治療薬・ワクチン市場
  • その他地域エボラ出血熱治療薬・ワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 新規薬剤タイプ別の世界のエボラ出血熱治療薬・ワクチン市場の成長機会
    • ワクチンタイプ別の世界のエボラ出血熱治療薬・ワクチン市場の成長機会
    • 菌株タイプ別の世界のエボラ出血熱治療薬・ワクチン市場の成長機会
    • 最終用途別の世界のエボラ出血熱治療薬・ワクチン市場の成長機会
    • 地域別の世界のエボラ出血熱治療薬・ワクチン市場の成長機会
  • 世界のエボラ出血熱治療薬・ワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のエボラ出血熱治療薬・ワクチン市場の生産能力拡大
    • 世界のエボラ出血熱治療薬・ワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Arbutus Biopharma
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Hemispherx Biopharma
  • BioCryst Pharmaceuticals
  • NanoViricides
  • NewLink Genetics
目次

Ebola Drug and Vaccine Trends and Forecast

The future of the global ebola drug and vaccine market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global ebola drug and vaccine market is expected to reach an estimated $168.7 million by 2030 with a CAGR of 28.6% from 2024 to 2030. The major drivers for this market are growing prevalence of infectious diseases and supportive government initiatives towards ebola research and development of ebola drugs and vaccines.

A more than 150-page report is developed to help in your business decisions.

Ebola Drug and Vaccine by Segment

The study includes a forecast for the global ebola drug and vaccine by novel drug type, vaccine type, strain type, end use, and region.

Ebola Drug and Vaccine Market by Novel Drug Type [Shipment Analysis by Value from 2018 to 2030]:

  • Zmapp
  • Favipiravir
  • Gs-5734
  • Tkm-Ebola
  • Avi-7537

Ebola Drug and Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Cad3-Zebov
  • Rvsv-Zebov
  • Others

Ebola Drug and Vaccine Market by Strain Type [Shipment Analysis by Value from 2018 to 2030]:

  • Zaire
  • Sudan
  • Tai Forest
  • Reston
  • Bundibugyo Virus

Ebola Drug and Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Ebola Drug and Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ebola Drug and Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ebola drug and vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ebola drug and vaccine companies profiled in this report include-

  • Arbutus Biopharma
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Hemispherx Biopharma
  • BioCryst Pharmaceuticals
  • NanoViricides
  • NewLink Genetics

Ebola Drug and Vaccine Market Insights

Lucintel forecasts that zaire is expected to witness highest growth over the forecast period.

North America will remain the largest regiondue to growing prevalence of zoonotic diseases, rising adoption of advanced medical technologies, and presence of well-established healthcare infrastructure in the region.

Features of the Global Ebola Drug and Vaccine Market

Market Size Estimates: Ebola drug and vaccine market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ebola drug and vaccine market size by various segments, such as by novel drug type, vaccine type, strain type, end use, and region in terms of ($M).

Regional Analysis: Ebola drug and vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different novel drug types, vaccine types, strain types, end uses, and regions for the ebola drug and vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ebola drug and vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the ebola drug and vaccine market size?

Answer: The global ebola drug and vaccine market is expected to reach an estimated $168.7 million by 2030.

Q.2 What is the growth forecast for ebola drug and vaccine market?

Answer: The global ebola drug and vaccine market is expected to grow with a CAGR of 28.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the ebola drug and vaccine market?

Answer: The major drivers for this market are growing prevalence of infectious diseases and supportive government initiatives towards ebola research and development of ebola drugs and vaccines.

Q4. What are the major segments for ebola drug and vaccine market?

Answer: The future of the ebola drug and vaccine market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.

Q5. Who are the key ebola drug and vaccine market companies?

Answer: Some of the key ebola drug and vaccine companies are as follows:

  • Arbutus Biopharma
  • GlaxoSmithKline
  • Johnson & Johnson Services
  • Hemispherx Biopharma
  • BioCryst Pharmaceuticals
  • NanoViricides
  • NewLink Genetics

Q6. Which ebola drug and vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that zaire is expected to witness highest growth over the forecast period.

Q7. In ebola drug and vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest regiondue to growing prevalence of zoonotic diseases, rising adoption of advanced medical technologies, and presence of well-established healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ebola drug and vaccine market by novel drug type (zmapp, favipiravir, gs-5734, tkm-ebola, and avi-7537), vaccine type (cad3-zebov, rvsv-zebov, and others), strain type (zaire, sudan, tai forest, reston, and bundibugyo virus), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ebola Drug and Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ebola Drug and Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ebola Drug and Vaccine Market by Novel Drug Type
    • 3.3.1: Zmapp
    • 3.3.2: Favipiravir
    • 3.3.3: Gs-5734
    • 3.3.4: Tkm-Ebola
    • 3.3.5: Avi-7537
  • 3.4: Global Ebola Drug and Vaccine Market by Vaccine Type
    • 3.4.1: Cad3-Zebov
    • 3.4.2: Rvsv-Zebov
    • 3.4.3: Others
  • 3.5: Global Ebola Drug and Vaccine Market by Strain Type
    • 3.5.1: Zaire
    • 3.5.2: Sudan
    • 3.5.3: Tai Forest
    • 3.5.4: Reston
    • 3.5.5: Bundibugyo Virus
  • 3.6: Global Ebola Drug and Vaccine Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ebola Drug and Vaccine Market by Region
  • 4.2: North American Ebola Drug and Vaccine Market
    • 4.2.1: North American Ebola Drug and Vaccine Market by Strain Type: Zaire, Sudan, Tai Forest, Reston, and Bundibugyo Virus
    • 4.2.2: North American Ebola Drug and Vaccine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Ebola Drug and Vaccine Market
    • 4.3.1: European Ebola Drug and Vaccine Market by Strain Type: Zaire, Sudan, Tai Forest, Reston, and Bundibugyo Virus
    • 4.3.2: European Ebola Drug and Vaccine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Ebola Drug and Vaccine Market
    • 4.4.1: APAC Ebola Drug and Vaccine Market by Strain Type: Zaire, Sudan, Tai Forest, Reston, and Bundibugyo Virus
    • 4.4.2: APAC Ebola Drug and Vaccine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Ebola Drug and Vaccine Market
    • 4.5.1: ROW Ebola Drug and Vaccine Market by Strain Type: Zaire, Sudan, Tai Forest, Reston, and Bundibugyo Virus
    • 4.5.2: ROW Ebola Drug and Vaccine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ebola Drug and Vaccine Market by Novel Drug Type
    • 6.1.2: Growth Opportunities for the Global Ebola Drug and Vaccine Market by Vaccine Type
    • 6.1.3: Growth Opportunities for the Global Ebola Drug and Vaccine Market by Strain Type
    • 6.1.4: Growth Opportunities for the Global Ebola Drug and Vaccine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Ebola Drug and Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Ebola Drug and Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ebola Drug and Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ebola Drug and Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Arbutus Biopharma
  • 7.2: GlaxoSmithKline
  • 7.3: Johnson & Johnson Services
  • 7.4: Hemispherx Biopharma
  • 7.5: BioCryst Pharmaceuticals
  • 7.6: NanoViricides
  • 7.7: NewLink Genetics